OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Association of Metabolomic Change and Treatment Response in Patients with Non-Alcoholic Fatty Liver Disease
Kwang Seob Lee, Yongin Cho, Hongkyung Kim, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1216-1216
Open Access | Times Cited: 7
Kwang Seob Lee, Yongin Cho, Hongkyung Kim, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1216-1216
Open Access | Times Cited: 7
Showing 7 citing articles:
Exploration of Early Diagnostic Biomarkers for Intestinal Barrier Dysfunction in Non-Alcoholic Fatty Liver Disease
庄巍 李
Advances in Clinical Medicine (2025) Vol. 15, Iss. 02, pp. 315-321
Closed Access
庄巍 李
Advances in Clinical Medicine (2025) Vol. 15, Iss. 02, pp. 315-321
Closed Access
Uncovering the Gut–Liver Axis Biomarkers for Predicting Metabolic Burden in Mice
Guiyan Yang, Rex Liu, Shahbaz Rezaei, et al.
Nutrients (2023) Vol. 15, Iss. 15, pp. 3406-3406
Open Access | Times Cited: 8
Guiyan Yang, Rex Liu, Shahbaz Rezaei, et al.
Nutrients (2023) Vol. 15, Iss. 15, pp. 3406-3406
Open Access | Times Cited: 8
The Aging Human Liver: The Weal and Woe of Evolutionary Legacy
Robert K. Gieseler, Thomas Schreiter, Ali Canbay
Zeitschrift für Gastroenterologie (2023) Vol. 61, Iss. 01, pp. 83-94
Open Access | Times Cited: 7
Robert K. Gieseler, Thomas Schreiter, Ali Canbay
Zeitschrift für Gastroenterologie (2023) Vol. 61, Iss. 01, pp. 83-94
Open Access | Times Cited: 7
Hepatoprotective efficacy and interventional mechanism of the panaxadiol saponin component in high-fat diet-induced NAFLD mice
Ai Mi, Qinxue Hu, Ying Liu, et al.
Food & Function (2023) Vol. 15, Iss. 2, pp. 794-808
Open Access | Times Cited: 7
Ai Mi, Qinxue Hu, Ying Liu, et al.
Food & Function (2023) Vol. 15, Iss. 2, pp. 794-808
Open Access | Times Cited: 7
Impact of Rosuvastatin on Metabolic Syndrome Patients with Moderate to Severe Metabolic Associated Fatty Liver Disease without Overt Diabetes: A Randomized Clinical Trial
Xuan Wang, Lu Lyu, Wei Li, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2024) Vol. 18, Iss. 9, pp. 103126-103126
Open Access | Times Cited: 2
Xuan Wang, Lu Lyu, Wei Li, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2024) Vol. 18, Iss. 9, pp. 103126-103126
Open Access | Times Cited: 2
Proteomics and Metabolomics in Biomedicine
Lucia Santorelli, Marianna Caterino, Michele Costanzo
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16913-16913
Open Access | Times Cited: 6
Lucia Santorelli, Marianna Caterino, Michele Costanzo
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16913-16913
Open Access | Times Cited: 6
Potential impact of ezetimibe on patients with NAFLD/NASH: a meta-analysis of randomized controlled trials
BoLun Jiao, Bing Wang, BoYan Liu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access
BoLun Jiao, Bing Wang, BoYan Liu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access
